CLINICAL_TRIALS
research
· 2025-10-23
Clinical Trial Update: Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals [Phase 1]
Summary
Phase 1 safety study evaluating a disrupted adenovirus-based cocaine vaccine for individuals with cocaine dependence.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Cocaine Dependence | Phase 1 | Status: RECRUITING